ESR1 and breast cancer: As regards, investigations detected that EA has inhibitory activity on BC growth through several pathways including apoptosis augmentation, cell cycle arrest, tumor angiogenesis suppression, antioxidant activity, and estrogen receptor gene regulation (Ahire et al., 2017; Kaur et al., 2021; Pirzadeh‐Naeeni et al., 2020).